- Home
- SNN
as 11-25-2025 1:15pm EST
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
| Founded: | 1856 | Country: | United Kingdom |
| Employees: | 17349 | City: | N/A |
| Market Cap: | 14.0B | IPO Year: | 1999 |
| Target Price: | $32.83 | AVG Volume (30 days): | 561.9K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 0.56 | EPS Growth: | 59.91 |
| 52 Week Low/High: | $23.69 - $38.79 | Next Earning Date: | 10-30-2025 |
| Revenue: | $5,944,000,000 | Revenue Growth: | 5.35% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Smith & Nephew SNATS Inc. News
SNN Breaking Stock News: Dive into SNN Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Hip Replacement Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability, Product Launches, Key Persons, and Revenue Forecasts
GlobeNewswire
a day ago
Viscosupplementation Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts
GlobeNewswire
4 days ago
Wound Care Market Report 2025: Global Market to Surpass $30 Billion by 2029, Driven by Advancements in Wound Care Technologies, Increasing Elderly Populations, and Rising Chronic Conditions
Morningstar Research
19 days ago
Analyst Report: Smith & Nephew plc
MT Newswires
19 days ago
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
Insider Monkey
a month ago
RBC Capital Raises Price Target on Smith & Nephew (SNN) Ahead of Capital Markets Day
GlobeNewswire
a month ago
Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
MT Newswires
a month ago
Smith & Nephew, UFC Extend Marketing Partnership
Compare SNN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SNN Smith & Nephew SNATS Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.